A 12-week Double-blind, Randomised, Parallel-group, Multi-centre Study Evaluating the Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD, According to Swedish Guidelines (SPIRIMILD)
Phase of Trial: Phase IV
Latest Information Update: 24 Sep 2014
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms SPIRIMILD
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 31 Oct 2013 Planned number of patients changed from 250 to 224 as reported by ClinicalTrials.gov.
- 30 Aug 2007 Status changed from in progress to completed.
- 30 Oct 2005 New trial record.